Literature DB >> 27037382

Who should be referred to a specialist pulmonary -hypertension centre - a referrer's guide.

Jay Suntharalingam1, Rob MacKenzie Ross2, Jacob Easaw3, Graham Robinson4, Gerry Coghlan5.   

Abstract

The introduction of pulmonary hypertension (PH)-specific drugs has allowed certain forms of PH to become more treatable. However, patients with these diseases can present to a number of medical specialties and can be challenging to identify, particularly in a non-specialist setting. This article provides guidance on who should be investigated and referred on to a specialist centre, highlighting the potential pitfalls during assessment.
© 2016 Royal College of Physicians.

Entities:  

Keywords:  Pulmonary hypertension; assessment; chronic thromboembolic pulmonary hypertension; pulmonary arterial hypertension; screening

Mesh：

Year:  2016        PMID： 27037382      PMCID： PMC4952966          DOI： 10.7861/clinmedicine.16-2-135

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN： 1470-2118            Impact factor:   2.659


  28 in total

1.  Pulmonary arterial hypertension in France: results from a national registry.

Authors:  Marc Humbert; Olivier Sitbon; Ari Chaouat; Michèle Bertocchi; Gilbert Habib; Virginie Gressin; Azzedine Yaici; Emmanuel Weitzenblum; Jean-François Cordier; François Chabot; Claire Dromer; Christophe Pison; Martine Reynaud-Gaubert; Alain Haloun; Marcel Laurent; Eric Hachulla; Gérald Simonneau
Journal:  Am J Respir Crit Care Med       Date:  2006-02-02       Impact factor: 21.405

2.  Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study.

Authors:  Eric Hachulla; Virginie Gressin; Loïc Guillevin; Patrick Carpentier; Elisabeth Diot; Jean Sibilia; André Kahan; Jean Cabane; Camille Francès; David Launay; Luc Mouthon; Yannick Allanore; Kiet Phong Tiev; Pierre Clerson; Pascal de Groote; Marc Humbert
Journal:  Arthritis Rheum       Date:  2005-12

3.  An official American Thoracic Society clinical practice guideline: diagnosis, risk stratification, and management of pulmonary hypertension of sickle cell disease.

Authors:  Elizabeth S Klings; Roberto F Machado; Robyn J Barst; Claudia R Morris; Kamal K Mubarak; Victor R Gordeuk; Gregory J Kato; Kenneth I Ataga; J Simon Gibbs; Oswaldo Castro; Erika B Rosenzweig; Namita Sood; Lewis Hsu; Kevin C Wilson; Marilyn J Telen; Laura M Decastro; Lakshmanan Krishnamurti; Martin H Steinberg; David B Badesch; Mark T Gladwin
Journal:  Am J Respir Crit Care Med       Date:  2014-03-15       Impact factor: 21.405

4.  Riociguat for the treatment of chronic thromboembolic pulmonary hypertension.

Authors:  Hossein-Ardeschir Ghofrani; Andrea M D'Armini; Friedrich Grimminger; Marius M Hoeper; Pavel Jansa; Nick H Kim; Eckhard Mayer; Gerald Simonneau; Martin R Wilkins; Arno Fritsch; Dieter Neuser; Gerrit Weimann; Chen Wang
Journal:  N Engl J Med       Date:  2013-07-25       Impact factor: 91.245

5.  Pulmonary arterial hypertension: thin-section CT predictors of epoprostenol therapy failure.

Authors:  Arnaud Resten; Sophie Maître; Marc Humbert; Olivier Sitbon; Frédérique Capron; Gérald Simoneau; Dominique Musset
Journal:  Radiology       Date:  2002-03       Impact factor: 11.105

6.  HIV-associated primary pulmonary hypertension. A case control study. Swiss HIV Cohort Study.

Authors:  M Opravil; M Pechère; R Speich; H I Joller-Jemelka; R Jenni; E W Russi; B Hirschel; R Lüthy
Journal:  Am J Respir Crit Care Med       Date:  1997-03       Impact factor: 21.405

7.  Hospitalization for pain in patients with sickle cell disease treated with sildenafil for elevated TRV and low exercise capacity.

Authors:  Roberto F Machado; Robyn J Barst; Nancy A Yovetich; Kathryn L Hassell; Gregory J Kato; Victor R Gordeuk; J Simon R Gibbs; Jane A Little; Dean E Schraufnagel; Lakshmanan Krishnamurti; Reda E Girgis; Claudia R Morris; Erika B Rosenzweig; David B Badesch; Sophie Lanzkron; Onyinye Onyekwere; Oswaldo L Castro; Vandana Sachdev; Myron A Waclawiw; Rob Woolson; Jonathan C Goldsmith; Mark T Gladwin
Journal:  Blood       Date:  2011-04-28       Impact factor: 22.113

8.  Echocardiography as an outcome measure in scleroderma-related pulmonary arterial hypertension: a systematic literature analysis by the EPOSS group.

Authors:  Otylia Kowal-Bielecka; Jerome Avouac; David Pittrow; Doerte Huscher; Frank Behrens; Christopher P Denton; Ivan Foeldvari; Marc Humbert; Marco Matucci-Cerinic; Peter Nash; Christian F Opitz; Lewis J Rubin; James R Seibold; Vibeke Strand; Daniel E Furst; Oliver Distler
Journal:  J Rheumatol       Date:  2009-12-01       Impact factor: 4.666

9.  Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT).

Authors:  Nazzareno Galiè; Marius M Hoeper; Marc Humbert; Adam Torbicki; Jean-Luc Vachiery; Joan Albert Barbera; Maurice Beghetti; Paul Corris; Sean Gaine; J Simon Gibbs; Miguel Angel Gomez-Sanchez; Guillaume Jondeau; Walter Klepetko; Christian Opitz; Andrew Peacock; Lewis Rubin; Michael Zellweger; Gerald Simonneau
Journal:  Eur Heart J       Date:  2009-08-27       Impact factor: 29.983

10.  Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach.

Authors:  D Mukerjee; D St George; B Coleiro; C Knight; C P Denton; J Davar; C M Black; J G Coghlan
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103
View more
  3 in total

1.  Outcomes of Pulmonary Arterial Hypertension Are Improved in a Specialty Care Center.

Authors:  Hongyang Pi; Chad M Kosanovich; Adam Handen; Michael Tao; Jacqueline Visina; Gabrielle Vanspeybroeck; Marc A Simon; Michael G Risbano; Aken Desai; Michael A Mathier; Belinda N Rivera-Lebron; Quyen Nguyen; Jennifer Kliner; Mehdi Nouraie; Stephen Y Chan
Journal:  Chest       Date:  2020-02-25       Impact factor: 9.410

2.  IMproving PULmonary hypertension Screening by Echocardiography: IMPULSE.

Authors:  Oliver Graham Slegg; James Alexander Willis; Fiona Wilkinson; Joseph Sparey; Christopher Basil Wild; Jennifer Rossdale; Robert Mackenzie Ross; John D Pauling; Kevin Carson; Sri Raveen Kandan; David Oxborough; Daniel Knight; Oliver James Peacock; Jay Suntharalingam; John Gerard Coghlan; Daniel Xavier Augustine
Journal:  Echo Res Pract       Date:  2022-10-19

Review 3.  Computed tomography appearances of the lung parenchyma in pulmonary hypertension.

Authors:  Robert W Foley; Nirav Kaneria; Rob V MacKenzie Ross; Jay Suntharalingam; Benjamin J Hudson; Jonathan Cl Rodrigues; Graham Robinson
Journal:  Br J Radiol       Date:  2020-09-11       Impact factor: 3.039
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.